{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:49:05Z","timestamp":1780447745567,"version":"3.54.1"},"reference-count":54,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"A Foundation Building Strength and NIH\/NIAMS","doi-asserted-by":"publisher","award":["R01AR053897"],"award-info":[{"award-number":["R01AR053897"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Nemaline myopathy is one of the most common non-dystrophic congenital myopathies. Individuals affected by this condition experience muscle weakness and muscle smallness, often requiring supportive measures like wheelchairs or respiratory support. A significant proportion of patients, approximately one-third, exhibit compound heterozygous nebulin mutations, which usually give rise to the typical form of the disease. Currently, there are no approved treatments available for nemaline myopathy. Our research explored the modulation of myostatin, a negative regulator of muscle mass, in combating the muscle smallness associated with the disease. To investigate the effect of myostatin inhibition, we employed a mouse model with compound heterozygous nebulin mutations that mimic the typical form of the disease. The mice were treated with mRK35, a myostatin antibody, through weekly intraperitoneal injections of 10 mg\/kg mRK35, commencing at two weeks of age and continuing until the mice reached four months of age. The treatment resulted in an increase in body weight and an approximate 20% muscle weight gain across most skeletal muscles, without affecting the heart. The minimum Feret diameter of type IIA and IIB fibers exhibited an increase in compound heterozygous mice, while only type IIB fibers demonstrated an increase in wild-type mice. In vitro mechanical experiments conducted on intact extensor digitorum longus muscle revealed that mRK35 augmented the physiological cross-sectional area of muscle fibers and enhanced absolute tetanic force in both wild-type and compound heterozygous mice. Furthermore, mRK35 administration improved grip strength in treated mice. Collectively, these findings indicate that inhibiting myostatin can mitigate the muscle deficits in nebulin-based typical nemaline myopathy, potentially serving as a much-needed therapeutic option.<\/jats:p>","DOI":"10.3390\/ijms242015124","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:46:13Z","timestamp":1697114773000},"page":"15124","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacological Inhibition of Myostatin in a Mouse Model of Typical Nemaline Myopathy Increases Muscle Size and Force"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-013X","authenticated-orcid":false,"given":"Johan","family":"Lindqvist","sequence":"first","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Granzier","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1425","DOI":"10.1212\/WNL.0000000000011458","article-title":"A Cross-Sectional Study of Nemaline Myopathy","volume":"96","author":"Amburgey","year":"2021","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/WCO.0b013e328364d681","article-title":"Recent advances in nemaline myopathy","volume":"26","author":"Romero","year":"2013","journal-title":"Curr. Opin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.nmd.2021.07.012","article-title":"Recent advances in nemaline myopathy","volume":"31","author":"Laitila","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10974-019-09519-9","article-title":"Nemaline myopathies: A current view","volume":"40","author":"Sewry","year":"2019","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e200056","DOI":"10.1212\/NXG.0000000000200056","article-title":"Clinical Manifestation of Nebulin-Associated Nemaline Myopathy","volume":"9","author":"Moreno","year":"2023","journal-title":"Neurol. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.nmd.2022.06.009","article-title":"Respiratory muscle function in patients with nemaline myopathy","volume":"32","author":"Gaytant","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40478-022-01400-0","article-title":"Severe ACTA1-related nemaline myopathy: Intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies","volume":"10","author":"Labasse","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.nmd.2020.08.356","article-title":"250th ENMC International Workshop: Clinical trial readiness in nemaline myopathy 6\u20138 September 2019, Hoofdorp, the Netherlands","volume":"30","author":"Neuhaus","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10974-019-09565-3","article-title":"Nebulin: Big protein with big responsibilities","volume":"41","author":"Yuen","year":"2020","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gohlke, J., Tonino, P., Lindqvist, J., Smith, J.E., and Granzier, H. (2021). The number of Z-repeats and super-repeats in nebulin greatly varies across vertebrates and scales with animal size. J. Gen. Physiol., 153.","DOI":"10.1085\/jgp.202012783"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eabn1934","DOI":"10.1126\/science.abn1934","article-title":"Structures from intact myofibrils reveal mechanism of thin filament regulation through nebulin","volume":"375","author":"Wang","year":"2022","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pelin, K. (2021). Nebulin: Size matters for optimal muscle function. J. Gen. Physiol., 153.","DOI":"10.1085\/jgp.202012848"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1096\/fj.10-176727","article-title":"Disrupted myosin cross-bridge cycling kinetics triggers muscle weakness in nebulin-related myopathy","volume":"25","author":"Ochala","year":"2011","journal-title":"FASEB J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"C1123","DOI":"10.1152\/ajpcell.00503.2008","article-title":"Reduced thin filament length in nebulin-knockout skeletal muscle alters isometric contractile properties","volume":"296","author":"Gokhin","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1083\/jcb.200603119","article-title":"Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle","volume":"173","author":"Bang","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/endrev\/bnab030","article-title":"Myostatin\/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs","volume":"43","author":"Rodgers","year":"2022","journal-title":"Endocr. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/er.2008-0003","article-title":"Clinical, agricultural, and evolutionary biology of myostatin: A comparative review","volume":"29","author":"Rodgers","year":"2008","journal-title":"Endocr. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13395-017-0141-y","article-title":"A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys","volume":"7","author":"Johnson","year":"2017","journal-title":"Skelet Muscle"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/s41467-020-16526-9","article-title":"Triggering typical nemaline myopathy with compound heterozygous nebulin mutations reveals myofilament structural changes as pathomechanism","volume":"11","author":"Lindqvist","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mancinelli, R., Checcaglini, F., Coscia, F., Gigliotti, P., Fulle, S., and Fano-Illic, G. (2021). Biological Aspects of Selected Myokines in Skeletal Muscle: Focus on Aging. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168520"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00018-022-04408-w","article-title":"Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases","volume":"79","author":"Abati","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1093\/hmg\/ddv243","article-title":"Nebulin deficiency in adult muscle causes sarcomere defects and muscle-type-dependent changes in trophicity: Novel insights in nemaline myopathy","volume":"24","author":"Li","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajpath.2010.10.035","article-title":"Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice","volume":"178","author":"Lawlor","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1748-1716.2012.02423.x","article-title":"The central role of myostatin in skeletal muscle and whole body homeostasis","volume":"205","author":"Elliott","year":"2012","journal-title":"Acta Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"C188","DOI":"10.1152\/ajpcell.00542.2005","article-title":"Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors","volume":"292","author":"Allen","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2013.12.003","article-title":"Myostatin signaling regulates Akt activity via the regulation of miR-486 expression","volume":"47","author":"Hitachi","year":"2014","journal-title":"Int J. Biochem. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mus.20175","article-title":"Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle","volume":"31","author":"Girgenrath","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"C525","DOI":"10.1152\/ajpcell.00259.2007","article-title":"Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression","volume":"296","author":"Hennebry","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jnen\/nly120","article-title":"Myostatin Inhibition Using ActRIIB-mFc Does Not Produce Weight Gain or Strength in the Nebulin Conditional KO Mouse","volume":"78","author":"Tinklenberg","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/hmg\/ddx431","article-title":"Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice","volume":"27","author":"Tinklenberg","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ajpath.2016.02.008","article-title":"Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy","volume":"186","author":"Tinklenberg","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s40478-022-01491-9","article-title":"NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy","volume":"10","author":"Ranu","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00401-019-02034-8","article-title":"Impairments in contractility and cytoskeletal organisation cause nuclear defects in nemaline myopathy","volume":"138","author":"Ross","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/brain\/awr004","article-title":"Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies","volume":"134","author":"Ravenscroft","year":"2011","journal-title":"Brain"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/brain\/awr274","article-title":"Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy","volume":"134","author":"Nguyen","year":"2011","journal-title":"Brain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2021.01.001","article-title":"Corrigendum to \u201cRandomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy\u201d [Neuromuscular Disorders 2020, 30, 492\u2013502]","volume":"31","author":"Wagner","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2020.05.002","article-title":"Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy","volume":"30","author":"Wagner","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1474-4422(22)00125-9","article-title":"Emerging therapies for Duchenne muscular dystrophy","volume":"21","author":"Markati","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.25144","article-title":"Dysfunctional sarcomere contractility contributes to muscle weakness in ACTA1-related nemaline myopathy (NEM3)","volume":"83","author":"Joureau","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jsb.2009.11.013","article-title":"Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2)","volume":"170","author":"Ottenheijm","year":"2010","journal-title":"J. Struct. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ochala, J., Ravenscroft, G., Laing, N.G., and Nowak, K.J. (2012). Nemaline myopathy-related skeletal muscle alpha-actin (ACTA1) mutation, Asp286Gly, prevents proper strong myosin binding and triggers muscle weakness. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045923"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1172\/JCI124000","article-title":"KBTBD13 is an actin-binding protein that modulates muscle kinetics","volume":"130","author":"Molenaar","year":"2020","journal-title":"J. Clin. Invest"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/NEN.0b013e318293b1cc","article-title":"Distinct underlying mechanisms of limb and respiratory muscle fiber weaknesses in nemaline myopathy","volume":"72","author":"Lindqvist","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lindqvist, J., Kolb, J., de Winter, J., Tonino, P., Hourani, Z., Labeit, S., Ottenheijm, C., and Granzier, H. (2022). Removal of MuRF1 Increases Muscle Mass in Nemaline Myopathy Models, but Does Not Provide Functional Benefits. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158113"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1113\/JP279943","article-title":"Myostatin inhibition promotes fast fibre hypertrophy but causes loss of AMP-activated protein kinase signalling and poor exercise tolerance in a model of limb-girdle muscular dystrophy R1\/2A","volume":"598","author":"Kramerova","year":"2020","journal-title":"J. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/brain\/awm094","article-title":"Distal myopathy caused by homozygous missense mutations in the nebulin gene","volume":"130","author":"Lehtokari","year":"2007","journal-title":"Brain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/humu.22693","article-title":"Mutation update: The spectra of nebulin variants and associated myopathies","volume":"35","author":"Lehtokari","year":"2014","journal-title":"Hum. Mutat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmor.1052210207","article-title":"Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb","volume":"221","author":"Burkholder","year":"1994","journal-title":"J. Morphol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2044-5040-4-21","article-title":"SMASH\u2014Semi-automatic muscle analysis using segmentation of histology: A MATLAB application","volume":"4","author":"Smith","year":"2014","journal-title":"Skelet Muscle"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/elps.200305392","article-title":"Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins","volume":"24","author":"Warren","year":"2003","journal-title":"Electrophoresis"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/20\/15124\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:05:53Z","timestamp":1760130353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/20\/15124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":54,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ijms242015124"],"URL":"https:\/\/doi.org\/10.3390\/ijms242015124","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]}}}